What condition primarily benefits from sapropterin therapy?

Sapropterin (the synthetic form of the cofactor tetrahydrobiopterin, BH₄) is most commonly used to treat phenylketonuria (PKU) in patients who are BH₄‑responsive. In these individuals, sapropterin lowers blood phenylalanine levels, allowing a more normal diet and better neurocognitive outcomes.